Quantcast

Silver State Times

Wednesday, December 18, 2024

FDA conducted second lowest number of inspections on Drugs companies in Nevada during 2023

Webp ijw6s7vbfr36c32lki2m95inya4m

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

In 2023, four Drugs companies received four FDA inspections in Nevada, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Nevada, equalling 8.5% of all inspections in 2023.

Of all the Nevada companies involved in the Drugs sector, Kent L. Wellish, M.D. received the most citations from the FDA in 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Nevada During 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring31--
Blood and Blood Products5----
Compliance: Devices1----
Food Composition, Standards, Labeling and Econ25--
Foodborne Biological Hazards2641
Human Cellular, Tissue, and Gene Therapies21--
Technical Assistance: Food and Cosmetics4----
Tobacco Post-Market Activities1----
Vaccines and Allergenic Products5----

MORE NEWS